John Alexender Bryson
Directeur/Membre du Conseil chez Bionics Institute
Profil
John Alexender Bryson is currently a Non-Executive Director at Bionics Institute.
Previously, he worked as an Independent Non-Executive Director at Praemium Ltd.
from 2011 to 2012 and as a Non-Executive Director at Choiseul Investments Ltd.
from 2010 to 2010.
He also served as a Director at Choiseul Investments Ltd.
(Fund Distributor).
Postes actifs de John Alexender Bryson
| Sociétés | Poste | Début |
|---|---|---|
Bionics Institute
 Bionics Institute Miscellaneous Commercial ServicesCommercial Services Bionics Institute is an independent medical research institute, affiliated with the University of Melbourne, undertaking medical bionics research and It focus particularly on neural prostheses. The company was founded by Graeme Clark on August 29,1984 and is headquartered in East Melbourne, Australia. | Directeur/Membre du Conseil | 01/04/2011 |
Anciens postes connus de John Alexender Bryson
| Sociétés | Poste | Fin |
|---|---|---|
| PRAEMIUM LIMITED | Directeur/Membre du Conseil | 30/03/2012 |
| Choiseul Investments Ltd. (Fund Distributor) | Directeur/Membre du Conseil | 18/05/2011 |
Choiseul Investments Ltd.
 Choiseul Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Choiseul Investments Limited is an Australian listed investment company that invests in a diversified portfolio of Australian shares, unit trusts and interest bearing securities. The company was established in 1911 and its shares listed on the Stock Exchange (ASX) in 1971. Choiseul seeks to invest for the long-term in well managed companies and trusts that have a profitable history and the likelihood of paying increasing dividends. Choiseul is not a speculative investor and does not sell its assets to increase profit for distribution to shareholders. Capital profits are reinvested by the Company for the benefit of shareholders. The company has a history of paying increasing dividends to its shareholders. Dividends will be declared by directors out of the company's operating profits which excludes any gains or losses on disposal of its portfolio of investments. Gains on disposal of investments are reinvested for the benefit of all shareholders. | Directeur/Membre du Conseil | 22/12/2010 |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| PRAEMIUM LIMITED | Technology Services |
| Entreprise privées | 3 |
|---|---|
| Choiseul Investments Ltd. (Fund Distributor) | |
Bionics Institute
Bionics Institute Miscellaneous Commercial ServicesCommercial Services Bionics Institute is an independent medical research institute, affiliated with the University of Melbourne, undertaking medical bionics research and It focus particularly on neural prostheses. The company was founded by Graeme Clark on August 29,1984 and is headquartered in East Melbourne, Australia. | Commercial Services |
Choiseul Investments Ltd.
Choiseul Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Choiseul Investments Limited is an Australian listed investment company that invests in a diversified portfolio of Australian shares, unit trusts and interest bearing securities. The company was established in 1911 and its shares listed on the Stock Exchange (ASX) in 1971. Choiseul seeks to invest for the long-term in well managed companies and trusts that have a profitable history and the likelihood of paying increasing dividends. Choiseul is not a speculative investor and does not sell its assets to increase profit for distribution to shareholders. Capital profits are reinvested by the Company for the benefit of shareholders. The company has a history of paying increasing dividends to its shareholders. Dividends will be declared by directors out of the company's operating profits which excludes any gains or losses on disposal of its portfolio of investments. Gains on disposal of investments are reinvested for the benefit of all shareholders. | Miscellaneous |